While discussing Amarin, will the company find a partner to help launch Vascepa, or perhaps a buyer?
New drug launches to watch in the last four months of 2012: Medivation's Xtandi,
I can't mention Vivus and ignore
, which is expected to receive DEA scheduling for Belviq before the end of the year so that the obesity drug can be launched early in 2013.
sign a partner before starting the bavituximab phase III lung cancer study at year's end, as promised?
Same goes for
: Where is the promised partner to co-develop the myelobfibrosis drug CYT387?
gather enough safety data to convince FDA to lift the clinical hold on its hepatitis C drugs? Will
, which like Idenix is seeking partners or buyers for its hepatitis C drugs, finally change its Facebook status to "In a Relationship?"
--Written by Adam Feuerstein in Boston.
>To contact the writer of this article, click here:
>To follow the writer on Twitter, go to
>To submit a news tip, send an email to:
and become a fan on